| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |